iRadimed Corporation IRMD

85.76 0.56 0.66% as of 25 Sep
Market cap
$1.1B
P/E
47.1×
Growth Flags show if company had growth for consecutive years
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
16.47 306.00 41.46 27.19 190.00 61.61 27.92 34.77 35.95 54.96
P/S ratio
3.73 7.05 8.65 6.85 8.72 13.64 6.71 9.09 9.51 14.77
P/FCF ratio
16.97 64.04 37.20 27.39 55.43 55.62 50.28 132.86 44.01 79.57
P/Operating CF
54.49 116.18 74.29 66.80 110.74 169.49 117.74 152.33 116.40 208.96
P/B ratio
3.80 4.94 6.27 4.75 4.50 7.90 4.86 8.34 8.03 13.08
EV/Sales
2.94 5.91 7.52 5.65 7.08 12.15 5.63 8.33 8.80 14.16
EV/EBITDA
8.04 52.60 32.18 21.99 385.25 45.26 18.40 26.26 28.29 43.44
EV/FCF
13.38 53.67 32.34 22.59 45.01 49.53 42.14 121.76 40.71 76.28
Current Ratio
9.25 8.61 9.50 10.06 12.96 11.18 9.06 4.65 8.84 7.98
Net Debt/EBITDA
(2.16) (10.16) (4.84) (4.68) (89.20) (5.57) (3.56) (2.39) (2.29) (1.87)
Debt/Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
22.61% 1.54% 16.84% 19.76% 2.34% 13.96% 17.59% 23.70% 24.31% 24.78%
ROA
19.92% 1.31% 14.42% 16.72% 1.99% 12.12% 15.24% 19.35% 20.20% 21.71%
ROIC
109.91% 12.19% 49.58% 58.28% (5.02%) 63.44% 62.16% 57.82% 39.69% 37.60%
Return on Tangible Assets
22.79% 1.52% 15.11% 17.46% 2.25% 13.04% 17.98% 24.93% 23.02% 23.69%
Average Days of Receivables
42.41 59.76 50.48 69.11 52.65 44.84 90.90 68.06 52.61 59.52
Earnings Yield
6.07% 0.33% 2.41% 3.68% 0.53% 1.62% 3.58% 2.88% 2.78% 1.82%
Free Cash Flow Yield
5.89% 1.56% 2.69% 3.65% 1.80% 1.80% 1.99% 0.75% 2.27% 1.26%
Free Cash Flow per Share
0.73 0.24 0.66 0.86 0.43 0.85 0.65 0.43 1.33 1.30
Book value per Share
2.95 3.10 3.90 4.92 5.06 5.85 5.86 5.67 6.85 7.44
Free Cash Flow
7.88 2.59 7.11 9.75 5.18 10.52 8.17 5.46 16.81 16.53
EV/EBIT
8.74 106.17 38.11 25.16 0.00 51.74 19.19 27.26 29.35 45.38
Other line items

Show all line items

Columns are period end dates